Scroll to discover
Some of the bacteria that comprise the microbiome play a critical role in maintaining health
These microbes can serve as live biotherapeutics — they have the potential to be harnessed as novel therapies for a wide range of indications
However, although most focus to date has been on the bacterial components of the microbiome, at least half of the microbiome is made up of viruses
Viruses that infect and kill bacteria are the most abundant types of viruses on the planet
.svg)
Swipe left to learn more
Viruses — tiny infectious agents that replicate solely inside the living cells of organisms are omnipresent
These viruses can limit the utility of beneficial bacteria
But bacteria are not defenseless against viruses. CRISPR-Cas, which represents nature’s first immune system, evolved in bacteria specifically to combat viruses.
Vaccines against viruses have been transformative for human health.
Leveraging CRISPR’s natural function to ‘vaccinate’ bacteria against predatory viruses will enable us to realize the full potential of beneficial bacteria as therapies and products.
But bacteria are not defenseless against viruses. CRISPR-Cas, which represents nature’s first immune system, evolved in bacteria specifically to combat viruses.
Vaccines against viruses have been transformative for human health.
Leveraging CRISPR’s natural function to ‘vaccinate’ bacteria against predatory viruses will enable us to realize the full potential of beneficial bacteria as therapies products.
But bacteria are not defenseless against viruses. CRISPR-Cas, which represents nature’s first immune system, evolved in bacteria specifically to combat viruses.
Vaccines against viruses have been transformative for human health.
Leveraging CRISPR’s natural function to ‘vaccinate’ bacteria against predatory viruses will enable us to realize the full potential of beneficial bacteria as therapies products.
Swipe left to learn more
Ancilia is harnessing the natural power of CRISPR to create beneficial bacterial products with immunity against destructive viruses
Ancilia is harnessing the natural power of CRISPR to create beneficial bacterial products with immunity against destructive viruses
Viruses are exceedingly diverse
There is no universal marker sequence for viruses
Viruses are difficult to grow & culture in the lab
Viruses are exceedingly diverse
There is no universal marker sequence for viruses
Viruses are difficult to grow & culture in the lab
Our CoVE platform tackles the uncharted territory of the virome by addressing the challenges of virome identification and characterization
The CoVE platform has the dual ability to computationally identify and characterize the virome and also design solutions to counter the destructive properties of specific viruses
Going forward, our CoVE platform will enable us to leverage our deep understanding of the virome to tackle a broad range of other virome-associated applications
Our CoVE™ platform tackles the uncharted territory of the virome by addressing the challenges of virome identification and characterization
The CoVE™ platform has the dual ability to computationally identify and characterize the virome and also design solutions to counter the destructive properties of specific viruses
Going forward, our CoVE™ platform and CRISPR tools and technologies will enable us to leverage our deep understanding of the virome to tackle a broad range of other virome-associated applications
Our proprietary CRISPR tools and technologies enable us to implement these solutions to develop new classes of live biotherapeutics and other bacterial products for a range of applications.
CRISPR-mediated viral immunity
Designed by nature, harnessed by Ancilia
3960 Broadway, 6th Floor
Alexandria Launchlabs
New York, NY 10032
© 2024 Ancilia Bio, Inc.
A product by
